IBI110,Sintilimab
eli lilly,Innovent Biologics
['ibi110', '$ivbxf', 'innovent']
$ivbxf new article : innovent presents phase 1b clinical data of ibi110 (anti-lag-3 monoclonal antibody) at the 2023 asco annual meeting 
Effortlessly track financial news and never miss an article again with https://t.co/hKE5DiO0B4. Our real-time database combines trusted financial news sources for easy access.